Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03424122
Brief Title: INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)

First Submitted : January 25, 2018
First Submitted that Met QC Criteria : January 31, 2018
First Posted : February 6, 2018

Last Update Submitted that Met QC Criteria : September 11, 2019
Last Update Posted : September 13, 2019